The Trump administration has removed WuXi AppTec, a key partner for the pharma industry, from its list of “Chinese military ...

We explain the CVS breakup, and why Democrats' election victories are good news for hospitals.

Novartis is largely abandoning a drug once considered a potential blockbuster after a study found it had little promise for ...

An AI engineer, Matteo is hardly naive about chatbots. “I know that there isn’t anyone reading this stuff on the other side.

Many in the party are pushing for Democratic lawmakers to go big on health care, but their dreams may crash into reality.

AI makes it easier for people to come up with new potential medicines, but may also increase the possibility of bad actors ...

So when it announced last Wednesday that it will split into two entities, the news made waves. Here’s the thing: Much of the ...

Liver doctors from around the world have come to agree on a definition for a common and potentially fatal liver complication.

A new study found survival after sudden cardiac arrest didn’t improve with advance training of responders — but researchers ...

Eli Lilly’s GLP-1 pill Foundayo helped alleviate sleep apnea in two late-stage studies, but it doesn’t appear as effective as Lilly’s injectable drug Zepbound.

These results, the fact that they're negative, does not invalidate that inflammation plays a very important role in ...

A Novartis drug lowered a risk marker for cardiovascular disease but did not lower chance of heart attack or stroke.